SBIR/STTR Research Award

Novel Biolabeling Methods and Reagents

Award identifier 238451d6cd568be6a9fbc28b32ed95af5b0378b9647c634a7bfc385eea0c6049Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Visigen Biotechnologies, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): A set of novel ATP-fluorescent-dye molecules and ATP-biotin molecules has been developed for the enzymatic, 5'-end-labeling of an oligonucleotide. This preliminary set is composed of unique linkers and either fluorescent dye or biotin combinations attached at the terminal (gamma)-phosphate of ATP. Enzymatic transfer of the labeled gamma-phosphate is mediated by T4 Polynucleotide Kinase (T4 PNK) resulting in the specific 5' end-labeling of a DMA or RNA molecule. We have identified labeling of RNA for use in microarray analyses as the first application for this novel technology, since current methods for labeling microarray targets are sequenced biased, inconsistent, and labor intensive. Our method requires minimal handling and results in exclusive labeling at the 5' end of the molecule resulting in minimal impact on hybridization. The goal of the Phase I project is to examine the labeling efficiencies of a library of labeled ATP variants and define the critical threshold for obtaining robust and reproducible signal intensities from labeled-targets hybridized to a microarray. A group of commonly-used, commercially-available fluorescent dyes along with biotin, have been selected for microarray testing. The chemical procedure for synthesizing each of the ATP-linker- molecule combinations has been developed in conjunction with a screening strategy that examines fluorescent-labeling and biotin-labeling of nucleic acids. Phase II of the project will involve mutagenizing key residues within T4 PNK to enhance its catalytic activity with the optimized Phase I library of ATP-molecules.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.